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Protein splicing is a naturally occurring process in which a protein editor, called an intein, performs
a molecular disappearing act by cutting itself out of a host protein in a traceless manner. In the two
decades since its discovery, protein splicing has been harnessed for the development of several
protein-engineering methods. Collectively, these technologies help bridge the fields of chemistry
and biology, allowing hitherto impossible manipulations of protein covalent structure. These tools
and their application are the subject of this Primer.Introduction
Molecular biologists have developed powerful methods to study
the details of protein function. Approaches such as X-ray crystal-
lography and site-directed mutagenesis have furnished count-
less insights, highlighting how even the most byzantine of
problems can yield to the right tools. Nonetheless, there is
always demand for more tools. This is perhaps best illustrated
by considering protein posttranslational modifications (PTMs).
Most, if not all, proteins are modified at some point; it is nature’s
way of imposing functional diversity on a single polypeptide
chain (Walsh et al., 2005). Moreover, many proteins are modified
in manifold ways as exemplified by the histones, where dozens
of discrete PTMs have been identified. Existing tools based on
site-directed mutagenesis offer limited opportunities for deter-
mining what all these PTMs are doing. Although it is straightfor-
ward to mutate a protein in such a way as to prevent a PTM from
being installed, the reverse strategy whereby a mutation is intro-
duced that mimics a PTM is a haphazard business at best. To fill
this and other voids, protein chemists have come up with an
array of approaches for the introduction of countless chemical
modifications into proteins, including all of the major types of
PTM.
The chemical modification of proteins can be accomplished
through a variety of means, including bioconjugation techniques
(Hermanson, 2008), total chemical synthesis (Kent, 2009),
enzyme-mediated reactions (Lin and Wang, 2008), nonsense
suppression mutagenesis (Wang et al., 2006), and a variety of
protein ligation methods (Hackenberger and Schwarzer, 2008).
The latter group of strategies include the protein semisynthesis
methods (defined as those where the protein is manufactured
from premade fragments one or both being recombinant in
origin) expressed protein ligation (EPL) and protein trans-splicing
(PTS) (Muir, 2003; Muralidharan and Muir, 2006; Mootz, 2009).
These are unique technologies in that they combine the power
of biotechnology, which provides accessibility to significant
amounts of large proteins, with the versatility of chemical
synthesis, which allows the site-specific incorporation of almost
any chemical modification into the target protein. In the followingsections we provide an overview of EPL and PTS and illustrate
how these technologies have been used to tackle problems in
molecular biology that have proven refractory to other methods.
Expressed Protein Ligation
Expressed protein ligation (EPL) allows a recombinant protein
and a synthetic peptide to be linked together undermild aqueous
conditions (Muir et al., 1998; Evans et al., 1998). The process
involves a chemoselective reaction that yields a final protein
product with a native peptide bond between its two building
blocks. The synthetic nature of one of the fragments enables
the site-specific introduction of almost any chemical modifica-
tion in the protein of interest, including fluorophores, caging
groups, crosslinkers, PTMs, and their analogs, as well as almost
any imaginable combination of modifications. At the same time,
the recombinant nature of the other fragment conveniently gives
access to large proteins, thereby overcoming the size restriction
associated with total chemical synthesis.
EPL is based on the well-known reaction between a polypep-
tide bearing a C-terminal thioester (a-thioester) and a peptide
possessing an N-terminal cysteine residue. This reaction,
termed native chemical ligation (NCL), originated in the field of
peptide chemistry and has proven extraordinarily powerful for
the total synthesis of small proteins and their analogs (Kent,
2009). However, the generation of large proteins using total
synthesis is still a daunting task for the nonspecialist, largely
due to the technical issues associated with performing the
multiple ligation reactions needed to access polypeptides
greater than100 amino acids. One solution to this size problem
is to employ recombinant polypeptide building blocks in the
process; indeed, this semisynthetic NCL approach was demon-
strated early on by using a recombinant protein fragment con-
taining an N-terminal cysteine (Erlanson et al., 1996). Nonethe-
less, the full integration of NCL and semisynthesis awaited the
development of a general approach to install an a-thioester
moiety into recombinantly derived proteins. The solution to this
problem came from the discovery of a most unusual PTM,
termed protein splicing (Paulus, 2000).Cell 143, October 15, 2010 ª2010 Elsevier Inc. 191
Figure 1. Mechanism of Protein Splicing
Protein splicing (A) and its variant protein trans-
splicing (B).Protein splicing is an autocatalytic process in which an inter-
vening protein domain (intein) excises itself from the polypeptide
in which it is embedded, concomitantly creating a new peptide
bond between its two flanking regions (exteins) (Figure 1). In
a sense, intein-mediated protein splicing is the protein equiva-
lent of RNA splicing involving self-splicing introns. Several
hundred inteins have been identified in unicellular organisms
from all three phylogenetic domains; all share conserved
sequence motifs and are derived from a common precursor
(for a complete listing, see http://www.neb.com/neb/inteins.
html). Thus, protein splicing is presumed to have an ancient
evolutionary origin. Parenthetically, although intein-mediated
protein splicing is not known to occur in multicellular organisms,
protein automodification processes do occur and involve intein-
like domains, most notably the hedgehog-like proteins that are
essential for embryonic development (Paulus, 2000). A biological
role for protein splicing in unicellular organisms has proven
elusive; modern inteins seem to be parasitic genetic elements
that are inserted into the open reading frames of (usually) essen-
tial genes. This frustration aside, the process has found a multi-
tude of applications in biotechnology (Noren et al., 2000) and
quickly attracted the interest of the peptide chemistry commu-
nity, as a-thioesters were identified as crucial intermediates in
the reaction mechanism (Figure 1). Several engineered inteins
have been developed that allow access to recombinant protein
a-thioester derivatives by thiolysis of the corresponding
C-terminal intein fusions (Figure 2). Moreover, inteins have also
been engineered to allow the introduction of an N-terminal
cysteine (Cys) moiety into recombinant proteins. Simple access
to reactive proteins without any size restriction through molec-192 Cell 143, October 15, 2010 ª2010 Elsevier Inc.ular biology techniques suddenly enabled
the application of NCL to the modification
of a much larger fraction of the proteome.
Indeed, the approach has been used to
generate semisynthetic derivatives of
members of essentially every major class
of protein including antibodies, integral
membrane proteins, cytoplasmic sig-
naling proteins, metabolic enzymes, and
transcription factors (Muir, 2003; Muralid-
haran and Muir, 2006).
Protein Trans-Splicing
A technology related to EPL, also based
on the use of inteins, is protein trans-
splicing (PTS, Figure 1). In PTS, artificially
or naturally split inteins are used to create
a new peptide bond between their flank-
ing exteins. Split inteins are characterized
by the fact that their primary sequence
is cut into two polypeptides giving an
N-terminal fragment (IntN) and a C-ter-minal fragment (IntC). Fragment complementation leads to
reconstitution of the canonical intein fold, recovery of protein
splicing activity, and ligation of the exteins. Importantly, several
split inteins have been described in which one of the two frag-
ments is small enough to be obtained by peptide synthesis,
thus allowing splicing reactions to be performed between a
recombinant fragment and a synthetic one (Table 1) (Mootz,
2009). This allows the generation of a semisynthetic protein
derivative upon PTS. Use of these autoprocessing domains to
carry out the ligation reaction precludes the need to isolate
a-thioesters or N-terminal Cys peptides or proteins and,
because the IntN and IntC fragments often have high affinity for
one another, the reaction can be carried out at very low concen-
trations (lowmicromolar) under native conditions. This should be
contrasted with EPL, which being a bimolecular process usually
requires high concentrations of reactants (ideally high micro-
molar range) to be efficient.
Applications of EPL and PTS
The simplest application of EPL or PTS is the modification of the
N- or C-terminal regions of a protein because this can be
achieved in a single ligation step involving a synthetic peptide
fragment, containing the desired chemical probe(s) and a
recombinant protein fragment. Central regions of the protein of
interest can also be labeled, but a three-piece ligation strategy
is then required (Muir, 2003), which is more technically chal-
lenging. It should be noted that EPL and PTS can be used to
link a recombinant protein to a nonpeptidic moiety, provided it
has the necessary reactive handles for ligation. Examples of
this include the attachment of proteins to surfaces, polymers,
Figure 2. Expressed Protein Ligation
The boxed region designates the native chemical ligation (NCL) reaction in which trans-thioesterification of the protein a-thioester by the N-terminal Cys poly-
peptide is followed by an S to N acyl shift to generate a new peptide bond linking the two polypeptides. a-thioesters can be obtained recombinantly, using
engineered inteins, or by chemical synthesis. N-terminal Cys polypeptides can also be produced recombinantly or made using standard solid-phase peptide
synthesis (SPPS) methods.and nucleic acids (Cheriyan and Perler, 2009). Ligation of two
fully recombinant protein domains is also possible and has
been used to generate toxic proteins that cannot normally be
expressed (Evans et al., 1998), as well as to label specific
domains within large proteins with isotopes for structural studies
using NMR (nuclear magnetic resonance) spectroscopy (Mura-
lidharan and Muir, 2006).
A key decision when performing EPL and PTS is the selection
of the ligation site. Obviously, this must be chosen such that the
region of interest in the protein corresponds to the synthetic
building block in the semisynthesis scheme. The only sequence
requirement for the standard EPL strategy is the Cys residue at
the ligation site—this makes EPL virtually traceless compared
with protein labeling methods involving the use of reactive
tags (Lin and Wang, 2008). Furthermore, recent developments
in the use of ligation auxiliaries as well as desulfurization
methods have broadened the scope of EPL to include other resi-
dues such as glycine (Gly), alanine (Ala), valine (Val), and phenyl-
alanine (Phe) at the ligation site; these more sophisticated
methods employ a Cys surrogate for the ligation step, which is
later converted into the native residue (Hackenberger and
Schwarzer, 2008). As an alternative to the use of traceless liga-
tion methods, it is also possible to simply mutate in a Cys
residue at a convenient site in the protein. Although a commonly
used strategy, care must be taken to minimize the structural
and functional impact of the mutation on the protein; a serine(Ser)/Ala/Cys mutation is often a good starting point (Valiya-
veetil et al., 2006a). An additional criterion to be considered
for EPL is the identity of the residue immediately upstream of
the Cys at the ligation site (which will be the residue adjacent
to the a-thioester in the N-terminal building block). Bulky,
b-branched amino acids, such as threonine (Thr), isoleucine
(Ile), and Val, slow-down the rate of the NCL reaction and should
be avoided, if possible.
The sequence requirements associated with PTS are some-
what more nebulous than those for EPL and depend to a great
extent on the exact split intein being used (Table 1) (Mootz,
2009). The mechanism of protein splicing dictates that, at
aminimum, the reaction will result in a Ser/Thr/Cys residue being
placed at the splice junction (Figure 1). However, in many cases,
there will be additional sequence requirements immediately
adjacent to this site. In particular, the commonly used cyanobac-
terial DnaE split inteins prefer to have three native C-extein resi-
dues (Cys-Phe-Asn) for optimal splicing efficiency (Mootz, 2009).
This restriction can be relaxed by using mutant split inteins
evolved to splice at non-native splice junctions, although the
Ser/Thr/Cys at the splice junction is still obligate (Lockless and
Muir, 2009).
A final consideration when choosing a ligation site is its posi-
tion within the secondary and tertiary structure of the protein.
Where possible the protein should be dissected between
modular domains as this will afford fragments that are wellCell 143, October 15, 2010 ª2010 Elsevier Inc. 193
Table 1. Split Inteins Commonly Used for PTS
Sizea
Half-Lifeb (min) CommentsIntN IntC
Naturally Split Inteins
Ssp DnaE 123 36 35–175 One of the better studied and broadly used split inteins. Requires three native extein
residues (Cys-Phe-Asn) at the C-terminal junction. IntC is accessible to SPPSc.
Npu DnaEd 102 36 1 Most efficient split intein described so far. Active with a broad set of residues at the splicing
junction. IntC is accessible to SPPS.
Artificially Split Inteins
Mtu RecA 105 38 60–120 Reconstitution of the active intein requires co-refolding of previously denatured fragments.
Sce VMA 184 55 6 Requires induced fragment complementation by auxiliary dimerization domains. Has been
used to control protein function in conditional protein splicing systems in vivo and in vitro.
Ssp DnaB-S0e 104 47 12 Active under native conditions. Ser-Gly required at the N-terminal junction.
Ssp DnaB-S1e 11 143 280 The short IntN is amenable to SPPS and has been used for the labeling of protein N termini.
Same sequence requirements as DnaB-S0.
Ssp GyrB-S11e 150 6 170 Active under native conditions. Ser-Ala-Asp used at the N-terminal junction.
a Number of residues.
bHalf-lives calculated from reported first-order rate constants.
c Solid-phase peptide synthesis.
d Artificial variants of the Npu DnaE, with shorter IntC (15 and 6 residues), have been designed by shifting the split site closer to the C terminus.
e S0, S1, and S11 indicate the site at which the intein is split. S0 corresponds to the split site of naturally split inteins.
Ssp: Synechotcystis sp.; Npu: Nostoc punctiforme; Sce: Saccharomyces cerevisiae; Mtu:Mycobacterium tuberculosis. (Mootz, 2009) and references
therein.behaved in terms of solubility and, importantly, preclude the
need for any folding step following the ligation reaction. The
need for well-behaved fragments is especially important when
using PTS because the process must be performed under
native-like conditions. If the protein can be efficiently refolded
then one naturally has more flexibility in choosing the ligation
site. In this case, EPL may be the method of choice given that
the actual ligation step can be performed in the presence of
a variety of additives, including chemical denaturants and deter-
gents (Muralidharan and Muir, 2006). Indeed, use of denaturants
is often beneficial for EPL reactions as it allows high concentra-
tions of reactants to be achieved, thereby improving the effi-
ciency of the bimolecular reaction.
The principal bottleneck of any project involving EPL or PTS is
the generation, by synthetic or recombinant means, of the reac-
tive protein fragments. As is usually the case in protein chem-
istry, each protein target presents its own set of (often unique)
challenges, and so some investment in strategy optimization
will be required for every system. Fortunately, after many years
of methodology development, an extensive array of tools is
now available for the generation of protein reactants for EPL
and PTS. An overview of commonly used approaches is given
in Table 1 and Table S1 (available online). These have allowed
a large number of systems to be interrogated through semisyn-
thesis including proteins that might, at first pass, seem beyond
the reach of organic chemistry, such as integral membrane
proteins.
EPL and PTS have been used to incorporate a variety of modi-
fications into proteins (Figure 3) to answer biological questions
that could not be addressed through more traditional
approaches. In the following sections we discuss examples of
these efforts and the biological insight they have revealed.194 Cell 143, October 15, 2010 ª2010 Elsevier Inc.Semisynthesis of Proteins Containing Posttranslational
Modifications
The most common application of EPL is in the semisynthesis of
posttranslationally modified proteins. PTMs are used to regulate
the activity of most proteins, and to fully understand how this is
achieved inevitably requires access to these modified proteins
for biochemical or structural studies. As noted earlier, standard
site-directed mutagenesis provides limited possibilities in this
regard. Thus, a clear opportunity exists for using more chemi-
cally driven approaches. EPL, in particular, has helped to fill
this void, aided by the availability of robust methods for the
chemical synthesis of peptides containing PTMs. Indeed, EPL
has been used to generate proteins modified through phosphor-
ylation, glycosylation, lipidation, ubiquitination, acetylation, as
well as several other classes of modification (Muir, 2003; Chat-
terjee and Muir, 2010). Below we focus on specific studies that
highlight important themes.
Phosphorylation
Phosphorylation is one of the most common and extensively
studied PTMs. It should not be surprising then that EPL has
been heavily utilized for the preparation of proteins containing
this modification. Indeed, the first report of EPL described the
semisynthesis of a phosphotyrosine (pTyr) containing analog of
the protein kinase Csk (Muir et al., 1998). Subsequently, EPL
has been used to create several phosphorylated proteins for
detailed functional and structural studies (Schwarzer and Cole,
2005; Muralidharan and Muir, 2006). This is exemplified by
biochemical and crystallographic analyses of semisynthetic
versions of the transcription factors Smad2 and Smad3, which
explain how bis-phosphorylation activates them through
homo- and heterotrimerization (Wu et al., 2001; Chacko et al.,
2004). This system has also served as a useful proving ground
Figure 3. Examples of Proteins Modfiied by
EPL and PTS
Expressed protein ligation (EPL) and protein trans-
splicing (PTS) can be used to site-specifically
modify a wide variety of structurally and function-
ally diverse proteins, as the examples given in
the figure illustrate. Modifications range from natu-
rally occurring posttranslational modifications
(PTMs) to unnatural moieties and include the
following: (A) D-amino acids (D-Ala), (B) ester
bonds, (C) acetylated (N-acetyl-Lys) and (D) meth-
ylated amino acids (N-tri-methyl-Lys), (E) phos-
pho-Ser/Thr, (F) ubiquitination, (G) isotopes (PET
emitting 18F), (H) fluorophores (fluorescein), (I)
photo-crosslinkers (photo-Met), (J) Ser-ATP bi-
substrate transition state analogs, (K), b turn
mimics (nipecotic acid), (L) photo-caging groups
(photo-caged phospho-Ser), (M) glycosylated
and (N) prenylated amino acids, (O) nonhydrolyz-
able analogs of AMP, and (P) nonhydrolyzable
phosphomimics (Tyr phosphonate).for several EPL-based technologies, including the incorporation
into proteins of new amino acid crosslinkers (Vila-Perello´ et al.,
2007) and various photoactivation strategies, including caged
phosphates (Hahn and Muir, 2004). One of the powers of
applying chemistry for the study of proteins is the ability to tweak
the covalent structure of the PTM. Cole and coworkers have
exploited this freedom to introduce various nonhydrolyzable
analogs of Ser/Thr/Tyr phosphorylation (termed phosphonates)
into proteins (Schwarzer and Cole, 2005). This strategy is partic-
ularly powerful in systems where the native phospho-amino acid
species is too short lived to permit detailed mechanistic studies.
For example, a semisynthetic version of the protein tyrosine
phosphatase, SHP-2, was prepared containing a stable tyrosine
phosphonate in place of the native pTyr (Lu et al., 2001). Subse-
quent microinjection of this protein into cells helped define a role
for this phosphorylation event in activation of the mitogen-acti-
vated kinase pathway.Cell 143,Lipidation
In terms of ease of chemical synthesis,
O-phosphorylation is among the lower-
hanging fruit of the PTM tree—this is
equally true for N-acetylation and
N-methylation, which have also been
introduced into semisynthetic proteins
(Chatterjee andMuir, 2010).Certainmodi-
fications such as lipidation, glycosylation,
and ubiquitination, however, present an
altogether different level of synthetic chal-
lenge due to their complexity and/or
physical attributes. Nonetheless, even
these have yielded to the EPL and PTS
approaches in recent years. Accordingly,
a variety of lipid modifications have been
introduced into proteins by EPL/PTS,
including prenyl groups and glycophos-
phatidylinositol (GPI) anchors (Brunsveld
et al., 2006). This is nicely illustrated by
the work of Goody and coworkers, whohave used semisynthesis in conjunction with structural and
functional approaches to study how lipidation regulates the func-
tion ofmembers of the Ras superfamily, including, most recently,
elucidation of the mechanism of membrane targeting of geranyl-
genanylated versions of a Rab GTPase (Wu et al., 2010).
Glycosylation
In terms of shear chemical complexity, glycosylation is arguably
the winner among the PTMs. The attached sugars can be
composed of several different monosaccharide building blocks
linked together in elaborate branched structures whose tailoring
can differ from molecule to molecule (Bertozzi and Kiessling,
2001). Studying the structural and functional consequences of
protein glycosylation is thus complicated by the inability to
isolate well-defined glycosylated proteins from natural sources.
Carbohydrate chemists have amassed an impressive arsenal
for the synthesis of complex oligosaccharides (Lepenies et al.,
2010). Recent years have seen this synthetic know-howOctober 15, 2010 ª2010 Elsevier Inc. 195
integrated with EPL for the preparation of homogeneous glyco-
proteins (Buskas et al., 2006). An impressive recent example of
this is the work of Unverzagt and coworkers, who synthesized
ribonuclease C, a 15 kDa enzymewith 4 disulfides and a bianten-
naric nonasaccharide, using a three-piece EPL strategy (Piontek
et al., 2009). In the coming years, we expect that the semisynthe-
sis of homogeneous glycoproteins will become more routine,
thereby allowing the role of this modification in the storage and
transfer of biological information to be examined in greater detail
than has hitherto been possible.
Ubiquitination
Ubiquitination is another example of a PTM difficult to study
using proteins isolated from natural sources. Ubiquitin (Ub) is
a 76 amino acid protein that is attached through its C terminus
to the 3-amino group of a lysine residue in a target protein.
Proteins can be monoubiquitinated, multiubiquitinated, or
polyubiquitinated, with the precise nature of this conjugation
dictating the functional consequences of the modification. The
E1–E3 protein ligase family is responsible for the attachment of
Ub to target proteins. Understanding the substrate specificity
and enzymology of these enzymes is an area of very active study.
Nonetheless, the details remain sufficiently obscure to make
in vitro ubiquitination of a target protein impractical (at least on
a preparative scale) in all but a few cases. Protein semisynthesis
provides an alternative source of ubiquitinated proteins. Indeed,
recent years have seen a flurry of reports describing chemical
methods to attach Ub to specific sites on a target protein
(McGinty et al., 2008; Li et al., 2009; Ajish Kumar et al., 2009;
Chatterjee et al., 2010; Chen et al., 2010). All of these strategies
employ inteins at one stage or another and allow the conjugation
of Ub to proteins through both native and non-native linkages.
Armed with these approaches, investigators have studied the
function of ubiquitination in several systems, including the role
of the PTM in regulating the activity of PCNA (involved in trans-
lesion DNA synthesis) (Chen et al., 2010) and histones (McGinty
et al., 2008; Chatterjee et al., 2010). These examples further high-
light a unique power of semisynthesis, namely the ability to
manipulate the structure of the PTM in ways that would be
impossible using an enzymatic approach. In particular, the
chemical approach permits Ub to be substituted for related
proteins (so-called ubiquitin-like proteins, Ubls), thereby allow-
ing structure-activity relationships to be explored. In the histone
example, the generation of a series of Ubl-modified mononu-
cleosomes aided in defining themechanism by which ubiquitina-
tion of histone H2B stimulates methylation of histone H3 by the
methyltransferase hDot1L (Chatterjee et al., 2010). More gener-
ally, the biochemical analysis of histone modifications appears
to be particularly fertile ground for the application of protein
semisynthesis. The majority of PTMs in histones are localized
in the flanking regions, making them readily accessible to EPL
and PTS. Indeed, several insights have already emerged from
the study of semisynthetic histones bearing chemically installed
PTMs (Chatterjee and Muir, 2010). We anticipate that this area
will continue to blossom in the years ahead.
Site-Specific Incorporation of Unnatural Building Blocks
EPL and PTS have been heavily utilized in the site-specific incor-
poration of unnatural amino acids into proteins. The ability to196 Cell 143, October 15, 2010 ª2010 Elsevier Inc.precisely tune the steric and electronic properties of amino acid
side chains is a powerful way to explore the details of protein
function; nowhere is this truer than for the study of enzymes.
Indeed, analogs of a number of enzymes (and their substrates)
have been prepared byEPL. These studies have furnishedmech-
anistic insights by manipulating various properties of key amino
acid side chains, including redox potential (as in the case of ribo-
nuclease reductase), nucleophilicity (such as the protein tyrosine
kinase Src), and steric bulk (for instance the GyrA intein)
(Schwarzer and Cole, 2005; Frutos et al., 2010). Semisynthesis
has also been used to incorporate transition state analogs into
enzymesand their substrates. This is exemplified by thedevelop-
ment of bi-substrate inhibitors (i.e., simultaneously targeting two
substrate-binding sites) of protein kinasesbasedonATP-peptide
conjugates that mimic the phosphoryl-transfer transition state
(Schwarzer and Cole, 2005). This strategy was recently used
to study the mechanism of autophosphorylation of full-length
protein kinase A (PKA) (Pickin et al., 2008). PKA has two regula-
tory phosphorylation sites: one in its activation loop, installed
by PDK1 (pyruvate dehydrogenase kinase 1), and the other one
at Ser338, thought to be autocatalyzed. Semisynthesis of PKA
with a pSer338-ATP analog was used to investigate whether
the autophosphorylation reaction was intra- or intermolecular.
A combination of biochemical and computational experiments
demonstrates that the pSer338-ATP moiety is docked into
the PKA active site in an intramolecular fashion, arguing that
Ser338 phosphorylation is an intramolecular event.
A related concept has recently been applied to the study of E1
ubiquitin ligases (Lu et al., 2010; Olsen et al., 2010). These
enzymes activate Ub and Ubls through adenylation (AMP) of
their C termini followed by thioesterification of a conserved
Cys residue in the enzyme. To probe the first half-reaction,
EPL was used to generate a reversible inhibitor by incorporating
a nonhydrolyzable analog of AMP, 50-O-sulfamoyladenosine
(AMSN), at the C terminus of Ub and the Ubl, SUMO (Lu et al.,
2010). A similar EPL approach was used to obtain a covalent
inhibitor of the second half-reaction, in this case by incorporating
a vinyl-sulfonamide electrophilic trap into the moiety (AVSN).
These elegant chemical biology studies have been followed up
by an equally impressive structural biology analysis (Olsen
et al., 2010). Specifically, the crystal structures of both SUMO-
AMSN and SUMO-AVSN in complex with the SUMO E1 were
solved, revealing that a major reorganization of the enzyme
active site accompanies the second half-reaction, that is, thioes-
terification of the E1. Examples like this highlight the utility of
semisynthesis in the study of enzymes. Nonetheless, we have
barely scratched the surface in terms of what is possible in this
area. There remain many exciting directions that have been
largely or wholly unexplored, including the notion of creating
new catalysts by integrating EPL/PTS with concepts and tools
emanating from the fields of computational protein design and
synthetic organic chemistry (e.g., novel organic catalysts).
Amino acid side chains account for 50% of the mass of
a typical protein; the remainder is composed of the main chain.
Backbone hydrogen bonding is, of course, critical to stabilizing
the secondary and tertiary structures of proteins and frequently
plays a direct role in enzyme catalysis and the recognition of
ligands. Unfortunately, the protein main chain constitutes a
‘‘blind spot’’ for standard mutagenesis, and consequently the
effects of backbonemodifications on protein structure and func-
tion are relatively unexplored compared to side-chain alter-
ations. Chemistry-driven protein-engineering approaches such
as EPL do allow changes to be made to the backbone of
a protein, and there are several excellent examples of this
(Muralidharan and Muir, 2006; Kent, 2009). For instance, Raines
and coworkers prepared analogs of the enzyme ribonuclease A
in which an entire unit of secondary structure, a b turn, was
replaced with a reverse-turn mimetic called nipecotic acid
(Arnold et al., 2002). The resulting ‘‘prosthetic’’ protein displayed
wild-type enzymatic activity but was thermodynamically more
stable than the native protein. Another approach to stabilizing
a protein involving a backbone change is through head-to-tail
cyclization. This can be achieved using either EPL or PTS, and
there are several examples of cyclic proteins exhibiting in-
creased stability (Muir, 2003).
As noted above, backbone interactions can play a direct role in
protein function, a point that is clearly illustrated by the selectivity
filter of potassium ion channels. This is a narrow, 12 A˚ long pore
lined with backbone carbonyl oxygen atoms that allows K+ ions
to pass through, but not other monovalent cations such as Na+.
Access to this region in a semisynthetic version of the bacterial
channel, KcsA, allowed the electronegativity of these carbonyl
groups to be attenuated through an amide-to-ester substitution
(Valiyaveetil et al., 2006b). Crystallographic and electrophysi-
ology studies on the resulting protein reveal alterations in ion
occupancy and conductance consistent with a model of
concerted ion conduction through the channel. The work on
KcsA provides another nice example of how chemistry can be
used to engineer the backbone of a protein, namely by engi-
neering the chirality of the polypeptide. Specifically, substitution
of a highly conserved Gly in the selectivity filter for a D-Ala shows
that the ability of the amino acid at that position to adopt a left-
handed helical conformation is absolutely required for activity,
and hence the native Gly residue acts as a D-amino acid surro-
gate (Valiyaveetil et al., 2006a). Electrophysiology and crystallo-
graphic studies demonstrate that the D-Ala-containing channel
is locked in an open conformation able to conduct Na+ in the
absence of K+. The work shows that selectivity is due in part to
the ability of the channel to structurally adapt in an ion-specific
manner to K+.
Site-Specific Incorporation of Biophysical Probes
EPL and PTS have proven to be extremely powerful for the site-
specific incorporation of spectroscopic probes into proteins
(Muralidharan and Muir, 2006; Mootz, 2009). After PTMs, the
incorporation of optical probes is the next most common appli-
cation of semisynthesis. In most cases, these semisynthetic
proteins are used to study ligand-binding events or internal
conformational changes in proteins, either by monitoring
changes in the fluorescence of a single strategically placed
probe in the protein or by employing multiple probes and using
fluorescence resonance energy transfer (FRET) between them.
These spectroscopic approaches are nicely showcased by the
work of Lorsch and coworkers, who carried out a series of
detailed thermodynamic and kinetic studies on the association
of fluorescent derivatives of eukaryotic initiation factors withthe ribosome (Maag et al., 2005). The generation of FRET-based
reporter proteins via EPL has also been used for the screening of
small-molecule inhibitors of biomedically important proteins
such as Abl kinase (Hofmann et al., 2001) and histone acetyl-
transferases (Xie et al., 2009). The former example highlights
a key attribute of EPL/PTS, namely the ability to incorporate
multiple noncoded elements, in this case two different fluoro-
phores, into a protein. This capacity is taken a step further by
a study in which five noncoded elements are incorporated into
the protein Smad2, namely, two phosphoserines, a fluorophore,
a fluorescent quencher, and a photocleavable trigger of activity
(Hahn et al., 2007). This protein was designed to be inactive
and nonfluorescent until irradiated with ultraviolet (UV) light
whereupon the protein activates (through trimerization) and
simultaneously becomes fluorescent. Microinjection of this
caged protein into mammalian cells allowed the levels of the bio-
logically active form of the protein to be precisely titrated (as
quantified by fluorescence) by varying the amount of irradiation
(Hahn et al., 2007).
EPL and PTS have also aided in the development of methods
for the structural characterization of proteins in solution using
NMR spectroscopy. NMR is a very powerful tool for the study
of protein structure and dynamics; however, spectral overlap
associated with large proteins limits its application. Both EPL
and PTS have been used to isotopically label specific regions,
or even atoms, of a protein in order to obtain simplified spectra
for detailed structural studies (Muralidharan and Muir, 2006).
In one recent example, which evokes the symbology of the
Uroboros (a mythical serpent that consumes its own tail), inteins
were actually used (via EPL) to make inteins containing site-
specific 15N and 13C isotopes (Frutos et al., 2010). NMR studies
on these proteins reveal that formation of the branched interme-
diate in the splicing reaction drastically alters the dynamic prop-
erties of the scissile amide bond between the intein and the
C-extein, rendering it more susceptible to nucleophilic attack.
In the so-called segmental isotopic labeling strategy (Muralid-
haran andMuir, 2006), the target protein is divided up into appro-
priate fragments, which are then expressed individually, allowing
uniform isotopic labeling of only the domain of interest. EPL or
PTS are then used to put the protein back together again via
one or more ligation steps. This strategy has been applied to
study specific domains (flanking aswell as internal) in the context
of larger proteins as well as to identify intramolecular interactions
or explore enzymatic mechanisms (Muralidharan and Muir,
2006). For example, Allain and coworkers prepared several
segmental labeled versions of the polypyrimidine tract-binding
protein and used these in conjunction with transverse-relaxation
optimized NMR spectroscopy to define domain-domain inter-
faces within the protein required for RNA binding (Vitali et al.,
2006). Themajority of segmental labeling studies have employed
samples generated in vitro using individually expressed building
blocks. This is often a technically demanding undertaking due to
the large amounts of protein needed for NMR studies. To
address this, Iwai and coworkers have demonstrated the feasi-
bility of performing segmental labeling within Escherichia coli
cells (Zu¨ger and Iwai, 2005). This employs a clever combination
of PTS and orthogonal promoter systems to allow the in vivo
reaction of a nonlabeled and labeled fragment of the protein.Cell 143, October 15, 2010 ª2010 Elsevier Inc. 197
Figure 4. In Vivo Applications of Protein
Splicing
(A) Schematic representation of intein-mediated
peptide or protein cyclization. The target polypep-
tide is expressed flanked by IntC and IntN at the
N and C termini, respectively. Protein trans-
splicing (PTS) results in the formation of a new
peptide bond between the N and C termini of the
target and thus generates a circularized peptide
or protein.
(B) Control of protein splicing through ligand-
induced intein complementation. The splicing
activity of artificially split inteins can be controlled
by fusion to exogenous auxiliary domains (in the
figure, a ligand-binding domain). A triggering event
(in the figure, ligand binding) causes a conforma-
tional change in the auxiliary domain, which
induces intein reconstitution and subsequent
protein splicing.This important advance not only promises easier access to
segmental labeled proteins for traditional structural studies but
also could have application in the emerging field of cell-based
protein NMR analysis.
In Vivo Applications of EPL and PTS
As we have already discussed, semisynthetic proteins prepared
in the test tube can be injected into cells for the purposes of
studying cell biological processes. This approach can be
extended to animal studies. For instance, EPL was recently
used to prepare a version of the protein hormone leptin contain-
ing an 18F-probe for PET (positron emission tomography)
imaging (Ceccarini et al., 2009). This molecule was used to study
the systemic biodistribution of the hormone in rodents and
primates, revealing, among other things, high-level uptake in
tissues undergoing hematopoiesis. This strategy aside, there
are many situations where it might be advantageous to perform
the protein chemistry inside the living cell or animal. In this
regard, PTS is especially powerful due to the availability of natu-
rally split cyanobacterial inteins that have no cross-reactivity with
any endogenous proteins in eukaryotic cells. Early work from our
own group demonstrated the potential of PTS for the in vivo
labeling of proteins by using the naturally split Ssp DnaE intein
for the traceless ligation of synthetic probes to heterologously
expressed proteins in mammalian cells (Giriat and Muir, 2003).
The efficiency of this cell-based semisynthesis approach is
sure to be improved by utilizing the recently described Nostoc
punctiforme DnaE intein, which possesses a series of remark-
able properties, including being the current record holder for
splicing kinetics (t1/2 1 min) (Mootz, 2009).
One of the most exciting uses of PTS is in the generation of
cyclic peptides in cells. Peptide cyclization is commonly used
inmedicinal chemistry (and in nature) to improve peptide stability
and bioactivity. The ability to biosynthesize cyclic peptides
in vivo offers the possibility of generating large genetically
encoded libraries for high-throughput screening purposes. This
can be accomplished by nesting the sequence (or library of
sequences) to be cyclized between the IntC and IntN intein frag-
ments. Flipping the order of the intein fragments in the precursor
ensures that PTS spits out a cyclic peptide (Scott et al., 1999).
This nifty technology, often referred to as SICLOPPS (split intein-198 Cell 143, October 15, 2010 ª2010 Elsevier Inc.mediated circular ligation of peptides and proteins, Figure 4A),
has been used to screen for inhibitors of several processes
(Cheriyan and Perler, 2009), includingmost recently the selection
of cyclic peptide inhibitors of a-synuclein toxicity in a yeast
model of Parkinson’s disease (Kritzer et al., 2009).
PTS results in a full-length active protein being generated from
two inactive split fragments. This functional output can be
harnessed for a variety of purposes. Umezawa and coworkers
have developed several cell-based biosensors based on the
activity of split inteins and used these for a variety of purposes,
including the identification of mitochondrial proteins (Ozawa
et al., 2003) and the monitoring of caspase activity (Kanno
et al., 2007). PTS has also found application in the area of
gene therapy. In a recent study, Li et al. expanded the scope
of adeno-associated virus (AAV) as a delivery vehicle for thera-
peutic genes (Li et al., 2008). AAV has several advantageous
properties as a vector but is handicapped by its limited usable
DNA capacity (4 kb). To overcome this, the authors created
two AAV vectors each carrying half of a therapeutic gene fused
in-frame to a split intein coding sequence. Coinfection of target
cells with the two AAV vectors leads to production of the thera-
peutic protein after PTS. As a proof of principle, the authors
demonstrated the production of a therapeutic dystrophin protein
upon codelivery of appropriate AAV vectors in a mouse model of
muscular dystrophy.
There are no known natural regulators of protein splicing.
Rather, the process appears to occur spontaneously after trans-
lation of the precursor protein. The idea of controlling protein
splicing is, nonetheless, attractive as this would provide a way
to trigger the posttranslational synthesis of a target protein. In
principle, such a system would be fast (compared to inducible
genes), tunable (allowing protein levels to be adjusted), and
portable (many inteins are remarkably promiscuous). With this
in mind, several conditional protein splicing systems have been
reported that respond to changes in temperature, light, protease
activity, and the presence of various small molecules (Cheriyan
and Perler, 2009; Mootz, 2009). These have been used to control
the activity of proteins both in cultured cells and in living animals.
Examples include the control of Notch signaling in Drosophila
melanogaster via a temperature-inducible intein mutant (Zeidler
et al., 2004) and the control of hedgehog signaling in mammalian
cells via a tamoxifen-inducible engineered intein (Figure 4B)
(Yuen et al., 2006). It should be stressed, however, that condi-
tional protein splicing does not work in every context due to
the, as yet, poorly understood functional interplay between the
intein and the surrounding extein sequences. Nevertheless, the
big advantage of this approach over mainstream small-molecule
screening initiatives is that different conditional intein constructs
can be easily surveyed using standard molecular biology tech-
niques.
Outlook
EPL and PTS have proven remarkably useful for studying protein
function in vitro and in vivo. The number of proteins studied by
semisynthesis is constantly growing, as is the complexity of
the modifications that can be introduced. In this Primer, our
aim is to provide a broad overview of the techniques and to intro-
duce selected systems that have been instrumental in unlocking
biological puzzles. As with any approach, EPL and PTS have
their strengths and weaknesses. The approaches are unparal-
leled in terms of the range and number of noncoded elements
that can be introduced into large proteins. However, they are
at their most practical when the regions to be modified are within
50 amino acids of the N or C terminus of the protein of interest,
given that this allows a single ligation step to be performed. The
interiors of proteins are far more difficult to access via semisyn-
thesis, requiring the use of technically demanding sequential
ligation reactions. This should be contrasted with the nonsense
suppression mutagenesis method. Although more restricted in
the types of modification that can be introduced, it does provide
general access to any part of the protein primary sequence
(Wang et al., 2006). Thus, EPL/PTS and nonsense suppression
are complementary protein-engineering approaches and the
decision to use one or the other will depend on the question at
hand. Moreover, there is no reason why the two approaches
cannot be used in combination, a tactic that we are now begin-
ning to see (Li et al., 2009) and that will surely bemore common in
the future.
A defined biological role for protein splicing has so far eluded
investigators—we currently know of no intein whose activity is
naturally regulated, something that would point the way to a bio-
logical purpose. Inteins are, however, very ancient proteins and
so such regulation may have been lost during evolution. What
we can say about inteins is that they are an amazingly malleable
platform for technologydevelopment. It is a fair bet that thechem-
ical biology communitywill continue to find newuses for inteins in
both the basic and applied biomedical sciences. Thus, these
remarkable protein deviceswill continue to be a part of the thread
that stitches together the fields of chemistry and biology.
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